GE HealthCare Technologies Inc.
GEHC
株式のランク
#771
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
株価
$69.86
最終同期: 2026-10-20
時価総額
$31.56B
変化（1日）
0.15%
変化（1年）
-8.19%
国
US
取引 GE HealthCare Technologies Inc. (GEHC)
カテゴリー
Healthcare
GE HealthCare Technologies Inc.（GEHC）の利益
Jun 2026 時点の利益 TTM: $2.04B
GE HealthCare Technologies Inc. の最新の財務報告によると、同社の現在の利益は $2.04B です。2024 年には $2.58B の利益を上げ、これは 2023 年の利益 $2.36B と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
GE HealthCare Technologies Inc. の利益の推移（2019 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $2.04B | -26.19% |
| 2025 | $2.77B | 7.25% |
| 2024 | $2.58B | 9.32% |
| 2023 | $2.36B | -6.01% |
| 2022 | $2.51B | -12.63% |
| 2021 | $2.88B | 6.09% |
| 2020 | $2.71B | 29.60% |
| 2019 | $2.09B | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $266.26M | -86.97% |
AU
|
|
| $295.53M | -85.53% |
US
|
|
| $-259.89M | -112.72% |
US
|
|
| $-74.89M | -103.67% |
US
|
|
| - | - |
US
|
